Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1-2 Study of the Pharmacology of Exenatide in Pediatric Sepsis

NCT01573806 is registered in ClinicalTrials.gov with Seattle Children's Hospital as lead sponsor.

NCT NCT01573806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01573806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1-2 Study of the Pharmacology of Exenatide in Pediatric Sepsis
Lead sponsor
Seattle Children's Hospital
Phase
Phase 1/2
Overall status
Withdrawn
Start date
October 31, 2012
Completion date
October 31, 2014
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glucose homeostasis, health-related quality of life, inflammation, organ dysfunction, septic shock